Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue

Gene

Volumn 233, Issue 1-2, 1999, Pages 163-170

  Wu, Xiaohong ^a   Gu, Howard H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Bupropion; Carrier; cDNA; Cocaine; Ritalin

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; COCAINE; COMPLEMENTARY DNA; DOPAMINE TRANSPORTER; METHYLPHENIDATE;

ANIMAL MODEL; ARTICLE; CELL STRAIN; DRUG ABUSE; DRUG DEPENDENCE; HUMAN; MICHAELIS MENTEN KINETICS; MOLECULAR CLONING; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; BRAIN; CARRIER PROTEINS; CELL LINE; CLONING, MOLECULAR; DNA PRIMERS; DOGS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; KINETICS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; NERVE TISSUE PROTEINS; RNA, MESSENGER;

ANIMALIA; RODENTIA;

EID: 0032784319     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(99)00143-2     Document Type: Article

References (38)

1. Amara S.G., Arriza J.L. Neurotransmitter transporters: three distinct gene families. Current Opin. Neurobiol. 3:1993;337-344.
2. Ascher J.A., Cole J.O., Colin J.N., Feighner J.P., Ferris R.M., Fibiger H.C., Golden R.N., Martin P., Potter W.Z., Richelson E., et al. Bupropion: a review of its mechanism of antidepressant activity. J. Clin. Psychiatry. 56:1995;395-401.
3. Barr L.C., Goodman W.K., Price L.H., McDougle C.J., Charney D.S. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. J. Clin. Psychiatry. 53:(Suppl.):1992;17-28.
4. Blakely R.D., Clark J.A., Rudnick G., Amara S.G. Vaccinia-T7 RNA polymerase expression system: evaluation for the expression cloning of plasma membrane transporters. Anal. Biochem. 194:1991;302-308.
5. Boyer W.F. Potential indications for the selective serotonin reuptake inhibitors. Int. Clin. Psychopharmacol. 6:(Suppl. 5):1992;5-12.
6. Donovan D.M., Vandenbergh D.J., Perry M.P., Bird G.S., Ingersoll R., Nanthakumar E., Uhl G.R. Human and mouse dopamine transporter genes: conservation of 5′-flanking sequence elements and gene structures. Brain Res. Mol. Brain Res. 30:1995;327-335.
7. Edwards J.G. Selective serotonin reuptake inhibitors. Br. Med. J. 304:1992;1644-1646.
8. Feinberg M. Bupropion: new therapy for depression. Am. Fam. Physician. 41:1990;1787-1790.
9. Fumagalli F., Gainetdinov R.R., Valenzano K.J., Caron M.G. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J. Neurosci. 18:1998;4861-4869.
10. Giros B., Caron M.G. Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14:1993;43-49.
11. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
12. Giros B., el Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T., Caron M.G. Cloning pharmacological characterization and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42:1992;383-390.
13. Goodnick P.J. Pharmacokinetics of second generation antidepressants: bupropion. Psychopharmacol. Bull. 27:1991;513-519.
14. Grahame N.J., Phillips T.J., Burkhart-Kasch S., Cunningham C.L. Intravenous cocaine self-administration in the C57BL/6J mouse. Pharmacol. Biochem. Behav. 51:1995;827-834.
15. Gu H., Wall S.C., Rudnick G. Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity kinetics, and ion dependence. J. Biol. Chem. 269:1994;7124-7130.
16. Gu H.H., Ahn J., Caplan M.J., Blakely R.D., Levey A.I., Rudnick G. Cell-specific sorting of biogenic amine transporters expressed in epithelial cells. J. Biol. Chem. 271:1996;18 100-18 106.
17. Guastella J., Nelson N., Nelson H., Czyzyk L., Keynan S., Miedel M.C., Davidson N., Lester H.A., Kanner B.I. Cloning and expression of a rat brain GABA transporter. Science. 249:1990;1303-1306.
18. Horn A.S. Dopamine uptake: a review of progress in the last decade. Prog. Neurobiol. 34:1990;387-400.
19. Iversen L.L. Role of transmitter uptake mechanisms in synaptic neurotransmission. Br. J. Pharmacol. 41:1971;571-591.
20. Kanner B.I., Schuldiner S. Mechanism of transport and storage of neurotransmitters. CRC Crit. Rev. Biochem. 22:1987;1-38.
21. Klein R.G. The role of methylphenidate in psychiatry. Arch. Gen. Psychiatry. 52:1995;429-433.
22. Koe B.K. Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake. J. Clin. Psychiatry. 51:(Suppl. B):1990;13-17.
23. Koob G.F. Drugs of abuse: anatomy pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:1992;177-184.
24. Kozak M. Structural features in eukaryotic mRNAs that modulate the initiation of translation. J. Biol. Chem. 266:1991;19 867-19 870.
25. Kuhar M.J., Ritz M.C., Boja J.W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14:1991;299-302.
26. Lopez-Ibor J.J. Jr. Obsessive compulsive disorder and other disorders. Int. Clin. Psychopharmacol. 7:(Suppl. 1):1992;25-26.
27. Mackler S.A., Eberwine J.H. The molecular biology of addictive drugs. Mol. Neurobiol. 5:1991;45-58.
28. Nelson N., Lill H. Porters and neurotransmitter transporters. J. Exp. Biol. 196:1994;213-228.
29. Pacholczyk T., Blakely R.D., Amara S.G. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature. 350:1991;350-354.
30. Rees S., Coote J., Stables J., Goodson S., Harris S., Lee M.G. Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein. Biotechniques. 20:1996;102-110.
31. Reith M.E., Sershen H., Lajtha A. Binding of [3H]cocaine in mouse brain: kinetics and saturability. J. Recept. Res. 2:1981;233-243.
32. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223.
33. Rudnick G., Clark J. From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim. Biophys. Acta. 1144:1993;249-263.
34. Sambrook J., Fritisch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
35. Seeman P., Madras B.K. Anti-hyperactivity medication: methylphenidate and amphetamine. Mol. Psychiatry. 3:1998;386-396.
36. Smith B.H., Pelham W.E., Gnagy E., Yudell R.S. Equivalent effects of stimulant treatment for attention-deficit hyperactivity disorder during childhood and adolescence. J. Am. Acad. Child Adolesc. Psychiatry. 37:1998;314-321.
37. Uhl G.R., Vandenbergh D.J., Miner L.L. Knockout mice and dirty drugs. Drug addiction. Curr. Biol. 6:1996;935-936.
38. Vandenbergh D.J., Persico A.M., Uhl G.R. A human dopamine transporter cDNA predicts reduced glycosylation displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. Brain Res. Mol. Brain Res. 15:1992;161-166.